The Global Crohn’s Disease Market: Pivoting Towards Biologics, Small Molecules, and the Treat-to-Target Strategy for Deep Remission

The Global Crohn’s Disease Market is experiencing dynamic growth, driven by the increasing global prevalence of this chronic, debilitating inflammatory bowel disease (IBD) and the revolutionary impact of Biologic Therapies on treatment outcomes. Crohn’s disease (CD) is characterized by chronic inflammation of the gastrointestinal (GI) tract, requiring complex and lifelong management. The primary market catalyst is the widespread adoption of biologic agents, including Anti-Tumor Necrosis Factor-alpha ($\text{TNF-}\alpha$) agents (like adalimumab and infliximab), Integrin Receptor Antagonists (like vedolizumab), and Interleukin ($\text{IL-12/23}$) inhibitors (like ustekinumab). These targeted therapies, which are genetically engineered proteins, have transformed the treatment paradigm for moderate-to-severe CD, moving the therapeutic goal from mere symptom relief to achieving mucosal healing and deep, sustained remission. Rising patient awareness, improved diagnostic capabilities (like endoscopy and advanced imaging), and the widespread adoption of the "treat-to-target"…

I was invited to participate on a team, and this is my first ever bike race and I was unaware that their was additional registration needed outside of the team. We paid for a 4 person team slot, but I did not register as a rider and now I am unable to do so. Is this something that I can still do?

Please let me know if you would like to take over this team. You can make the transfer at bib pick up tomorrow!

Looking for a female for a coed team. Our female teammate had a family funeral and can not race. Thank Ty Hall